{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:51:38Z","timestamp":1792428698498,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T00:00:00Z","timestamp":1318377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00380-011-0191-8","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T07:54:00Z","timestamp":1318319640000},"page":"419-423","source":"Crossref","is-referenced-by-count":11,"title":["L\/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action"],"prefix":"10.1007","volume":"27","author":[{"given":"Shizuka","family":"Aritomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Konda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,12]]},"reference":[{"key":"191_CR1","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1016\/0895-7061(96)87762-4","volume":"9","author":"FH Leenen","year":"1996","unstructured":"Leenen FH (1996) Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines. Am J Hypertens 9:97S\u2013104S","journal-title":"Am J Hypertens"},{"key":"191_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/HJH.0b013e3280104dba","volume":"25","author":"M Lindqvist","year":"2007","unstructured":"Lindqvist M, Kahan T, Melcher A, Ekholm M, Hjemdahl P (2007) Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity. J Hypertens 25:169\u2013175","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"191_CR3","first-page":"23","volume":"62","author":"PA Zwieten van","year":"1986","unstructured":"van Zwieten PA, de Jonge A (1986) Interaction between the adrenergic and renin\u2013angiotensin\u2013aldosterone-systems. Postgrad Med J 62(Suppl 1):23\u201327","journal-title":"Postgrad Med J"},{"key":"191_CR4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/00004872-199715120-00015","volume":"15","author":"SR Holmer","year":"1997","unstructured":"Holmer SR, Kaissling B, Putnik K, Pfeifer M, Kramer BK, Riegger GA, Kurtz A (1997) Beta-adrenergic stimulation of renin expression in vivo. J Hypertens 15:1471\u20131479","journal-title":"J Hypertens"},{"issue":"2","key":"191_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11897-004-0024-5","volume":"1","author":"SR Goldsmith","year":"2004","unstructured":"Goldsmith SR (2004) Interactions between the sympathetic nervous system and the RAAS in heart failure. Curr Heart Fail Rep 1(2):45\u201350","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"191_CR6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/eurjhf\/hfq049","volume":"12","author":"F Zannad","year":"2010","unstructured":"Zannad F, McMurray JJ, Drexler H, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B (2010) Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail 12(6):617\u2013622","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"191_CR7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309\u20131321","journal-title":"N Engl J Med"},{"issue":"1","key":"191_CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(99)00237-X","volume":"373","author":"H Uneyama","year":"1999","unstructured":"Uneyama H, Uchida H, Konda T, Yoshimoto R, Akaike N (1999) Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2+ channels. Eur J Pharmacol 373(1):93\u2013100","journal-title":"Eur J Pharmacol"},{"key":"191_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1254\/jjp.69.119","volume":"69","author":"M Hosono","year":"1995","unstructured":"Hosono M, Himura T, Watanabe K, Hayashi Y, Ohnishi H, Takata Y, Kato H (1995) Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats. Jpn J Pharmacol 69:119\u2013125","journal-title":"Jpn J Pharmacol"},{"key":"191_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1254\/jjp.75.27","volume":"75","author":"A Takahara","year":"1997","unstructured":"Takahara A, Dohmoto H, Hisa H, Satoh S, Yoshimoto R (1997) Cilnidipine attenuates renal nerve stimulation-induced renal vasoconstriction and antinatriuresis in anesthetized dogs. Jpn J Pharmacol 75:27\u201332","journal-title":"Jpn J Pharmacol"},{"key":"191_CR11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(01)00738-5","volume":"413","author":"T Konda","year":"2001","unstructured":"Konda T, Takahara A, Maeda K, Dohmoto H, Yoshimoto R (2001) Effects of a dual L\/N-type Ca2+ channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs. Eur J Pharmacol 413:117\u2013120","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"191_CR12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00044011-200525120-00004","volume":"25","author":"HW Tan","year":"2005","unstructured":"Tan HW, Li L, Zhang W, Ma ZY, Zhong XZ, Li JJ, Wang Y (2005) Effects of cilnidipine on fibrinolysis in Chinese hypertensive patients. Clin Drug Investig 25(12):777\u2013783","journal-title":"Clin Drug Investig"},{"issue":"12","key":"191_CR13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1291\/hypres.28.1003","volume":"28","author":"S Hoshide","year":"2005","unstructured":"Hoshide S, Kario K, Ishikawa J, Eguchi K, Shimada K (2005) Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure. Hypertens Res 28(12):1003\u20131008","journal-title":"Hypertens Res"},{"issue":"2","key":"191_CR14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000210396","volume":"30","author":"T Konda","year":"2009","unstructured":"Konda T, Enomoto A, Aritomi S, Niinuma K, Koganei H, Ogawa T, Nitta K (2009) Different effects of L\/N-type and L-type calcium channel blockers on the renin\u2013angiotensin\u2013aldosterone system in SHR\/Izm. Am J Nephrol 30(2):155\u2013161","journal-title":"Am J Nephrol"},{"issue":"2","key":"191_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/hr.2010.191","volume":"34","author":"S Aritomi","year":"2011","unstructured":"Aritomi S, Wagatsuma H, Numata T, Uriu Y, Nogi Y, Mitsui A, Konda T, Mori Y, Yoshimura M (2011) Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis. Hypertens Res 34(2):193\u2013201","journal-title":"Hypertens Res"},{"key":"191_CR16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.HYP.0000171587.44736.ba","volume":"46","author":"M Yoneda","year":"2005","unstructured":"Yoneda M, Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Sasaki M, Katoh T, Watanabe T, Andrews PM, Jose PA, Felder RA (2005) Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats. Hypertension 46:58\u201365","journal-title":"Hypertension"},{"issue":"1\u20133","key":"191_CR17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2008.12.041","volume":"605","author":"T Isaka","year":"2009","unstructured":"Isaka T, Ikeda K, Takada Y, Inada Y, Tojo K, Tajima N (2009) Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R. Eur J Pharmacol 605(1\u20133):49\u201352","journal-title":"Eur J Pharmacol"},{"issue":"25","key":"191_CR18","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0024-3205(01)01078-5","volume":"68","author":"W Zhang","year":"2001","unstructured":"Zhang W, Wang Z (2001) Resetting baroreceptors to a lower arterial pressure level by enalapril avoids baroreflex mediated activation of sympathetic nervous system by nifedipine. Life Sci 68(25):2769\u20132779","journal-title":"Life Sci"},{"issue":"5","key":"191_CR19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1476-5381.2009.00407.x","volume":"158","author":"A Takahara","year":"2009","unstructured":"Takahara A, Nakamura Y, Wagatsuma H, Aritomi S, Nakayama A, Satoh Y, Akie Y, Sugiyama A (2009) Long-term blockade of L\/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart. Br J Pharmacol 158(5):1366\u20131374","journal-title":"Br J Pharmacol"},{"issue":"4","key":"191_CR20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/hr.2010.279","volume":"34","author":"H Toba","year":"2011","unstructured":"Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T (2011) L\/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin\u2013angiotensin\u2013aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Hypertens Res 34(4):521\u2013529","journal-title":"Hypertens Res"},{"issue":"10","key":"191_CR21","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1097\/HJH.0b013e32833d01dd","volume":"28","author":"T Konoshita","year":"2010","unstructured":"Konoshita T, Makino Y, Kimura T, Fujii M, Wakahara S, Arakawa K, Inoki I, Nakamura H, Miyamori I, Genomic Disease Outcome Consortium Study Investigators (2010) A new-generation N\/L-type calcium channel blocker leads to less activation of the renin\u2013angiotensin system compared with conventional L type calcium channel blocker. J Hypertens 28(10):2156\u20132160","journal-title":"J Hypertens"},{"key":"191_CR22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.85.7.643","volume":"85","author":"DE Dostal","year":"1999","unstructured":"Dostal DE, Baker KM (1999) The cardiac renin\u2013angiotensin system: conceptual, or a regulator of cardiac function? Circ Res 85:643\u2013650","journal-title":"Circ Res"},{"issue":"1","key":"191_CR23","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1152\/ajpregu.00424.2007","volume":"294","author":"JC Ferreira","year":"2008","unstructured":"Ferreira JC, Bacurau AV, Evangelista FS, Coelho MA, Oliveira EM, Casarini DE, Krieger JE, Brum PC (2008) The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Am J Physiol Regul Integr Comp Physiol 294(1):R26\u2013R32","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"191_CR24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00380-009-1171-0","volume":"25","author":"Q Zhao","year":"2010","unstructured":"Zhao Q, Wu TG, Lin Y, Li B, Luo JY, Wang LX (2010) Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction. Heart Vessels 25(2):97\u2013103","journal-title":"Heart Vessels"},{"key":"191_CR25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.bjp.0701342","volume":"122","author":"H Uneyama","year":"1997","unstructured":"Uneyama H, Takahara A, Dohmoto H, Yoshimoto R, Inoue K, Akaike N (1997) Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones. Br J Pharmacol 122:37\u201342","journal-title":"Br J Pharmacol"},{"key":"191_CR26","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.HYP.33.6.1447","volume":"33","author":"K Sakata","year":"1999","unstructured":"Sakata K, Shirotani M, Yoshida H, Nawada R, Obayashi K, Togi K, Miho N (1999) Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension 33:1447\u20131452","journal-title":"Hypertension"},{"issue":"6","key":"191_CR27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00380-010-0005-4","volume":"25","author":"S Aritomi","year":"2010","unstructured":"Aritomi S, Koganei H, Wagatsuma H, Mitsui A, Ogawa T, Nitta K, Konda T (2010) The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet. Heart Vessels 25(6):549\u2013555","journal-title":"Heart Vessels"},{"issue":"10","key":"191_CR28","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/HJH.0b013e3282c2fa62","volume":"25","author":"S Morimoto","year":"2007","unstructured":"Morimoto S, Yano Y, Maki K, Iwasaka T (2007) Renal and vascular protective effects of cilnidipine in patients with essential hypertension. J Hypertens 25(10):2178\u20132183","journal-title":"J Hypertens"},{"issue":"6","key":"191_CR29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/10641961003667914","volume":"32","author":"Y Miwa","year":"2010","unstructured":"Miwa Y, Tsuchihashi T, Ohta Y, Tominaga M, Kawano Y, Sasaguri T, Ueno M, Matsuoka H (2010) Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin\u2013angiotensin-system inhibitors\u2014a multicenter, open, randomized trial using 24-hour urine collection. Clin Exp Hypertens 32(6):400\u2013405","journal-title":"Clin Exp Hypertens"},{"key":"191_CR30","doi-asserted-by":"crossref","unstructured":"Fujita T, Ando K, Nishimura H, Ideura T, Yasuda G, Isshiki M, Takahashi K; Cilnidipine versus Amlodipine Randomised Trial for Evaluation in Renal Disease(CARTER) Study Investigators (2007) Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin\u2013angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int 72(12):1543\u20131549","DOI":"10.1038\/sj.ki.5002623"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-011-0191-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-011-0191-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-011-0191-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:09:07Z","timestamp":1559056147000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-011-0191-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["191"],"URL":"https:\/\/doi.org\/10.1007\/s00380-011-0191-8","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,12]]}}}